Current and Past Trainees

Tobias B. Kulik, MD, PhD (2010-present)

Current Position: PGY-4 Chief Resident in Neurology, University of Rochester

Publications & Presentations

  • Kulik TB, Aronhime SN, Echeverry G, Beylin A, Winn HR. The relationship between oxygen and adenosine in astrocytic cultures. Glia. 2010 Aug 15;58(11):1335-44.
  • Kulik T., Nedergaard M. and Winn HR. Changes in extracellur potassium concentrations within the physiological range affect extracellular adenosine levels and dynamics in astrocytic cultures. Neurology 78:P01.029 April 22, 2012.
  • Kulik T., Nedergaard M.: Adenosine: A mediator of normobaric hyperoxic vaso-constriction? New York State Neurological Society Meeting, October 11, 2011.
  • Kulik T., Nedergaard M. and Winn HR. Changes in extracellar potassium concentrations within the physiological range affect extracellular adenosine levels and dynamics in astrocytic cultures. 64th Annual American Academy of Neurology Meeting, New Orleans, Louisiana, April 21-28, 2012.

Matthew Bellizzi, MD, PhD (2007-2011)

Current Position: Senior Instructor (Neuroimmunology), University of Rochester

Awards & Publications

  • 2012-15, National MS Society - AAN Clinician Scientist Development Award, title Synaptic injury and neuroprotection in multiple sclerosis. Role: PI.
  • Bellizzi MJ, Lu SM, Gelbard HA. Protecting the synapse: evidence for a rational strategy to treat HIV-1 associated neurologic disease. J Neuroimmune Pharmacol. 2006 Mar;1(1):20-31. Review.

Roberto Fernandez, MD, PhD (2007-2011)

Current Position: Assistant Professor of Neurology, University of Virginia


  • Fernandez R, Monacelli A, Duffy CJ. Visual motion event related potentials distinguish aging and Alzheimer's disease. J Alzheimers Dis. 2013 Jan 1;36(1):177-83.
  • Fernandez R, Duffy CJ. Early Alzheimer's disease blocks responses to accelerating self-movement. Neurobiol Aging. 2012 Nov;33(11):2551-60.

Marc W. Halterman, MD, PhD (2002-2006)

Current Position: Associate Professor of Neurology, University of Rochester

Awards & Publications

  • 2008-13, NINDS/NIH K99/R00 training award recipient. Project title: Defining neurotherapeutic targets in hypoxia-induced chop-10 signaling networks (K99NS060764). Role: PI
  • Halterman MW, Giuliano RE, Bowers WJ, Federoff HJ. Improved HSV-1 amplicon packaging using virion host shutoff mutants lacking mRNAse activity. J Gene Med. 2006 Nov;8(11):1320-8.
  • Halterman MW, Vates GE, Riggs G. Teaching NeuroImage: tremor in aqueductal stenosis and response to endoscopic third ventriculostomy. Neurology. 2007 May 8;68(19):E29-31.
  • Halterman MW, De Jesus C, Rempe DA, Schor NF, Federoff HJ. Loss of c/EBP-beta activity promotes the adaptive to apoptotic switch in hypoxic cortical neurons. Mol Cell Neurosci. 2008 Jun;38(2):125-37.

Jill W. Miller, MD, PhD (2000-2004)

Current Position: Neurologist, Viera Hospital, Kindred Rehab Hospital, Melborne, Florida


  • Lin X, Miller JW, Mankodi A, Kanadia RN, Yuan Y, Moxley RT, Swanson MS, Thornton CA. Failure of MBNL1-dependent post-natal splicing transitions in myotonic dystrophy. Hum Mol Genet. 2006 Jul 1;15(13):2087-97.
  • Heatwole CR, Miller J, Martens B, Moxley RT 3rd. Laboratory abnormalities in ambulatory patients with myotonic dystrophy type 1. Arch Neurol. 2006 Aug;63(8):1149-53.

David Rempe, MD, PhD (1996-2000)

Current Position: Medical Director, Stroke Division, Mercy Hospital, St. Louis

Awards & Publications

  • 2003-2008, NINDS/NIH K08 training award recipient. Project Title: The role of hypoxia inducible factor-1 alpha in stroke (NS046633-01). Role: PI
  • Rempe DA, Kent TA. Using bone marrow stromal cells for treatment of stroke. Neurology. 2002 Aug 27;59(4):486-7.
  • Rempe DA, Lelli KM, Vangeison G, Johnson RS, Federoff HJ. In cultured astrocytes, p53 and MDM2 do not alter hypoxia-inducible factor-1alpha function regardless of the presence of DNA damage. J Biol Chem. 2007 Jun 1;282(22):16187-201.